Dualitas
Boston, United States· Est.
Dualitas focuses on creating dual-targeting therapeutics, particularly bispecific antibodies, to treat complex diseases like cancer and autoimmune disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $65M
About
Dualitas focuses on creating dual-targeting therapeutics, particularly bispecific antibodies, to treat complex diseases like cancer and autoimmune disorders.
OncologyImmunologyAntibodies
Funding History
1Total raised:$65M
Series A$65M